Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trugman

Showing results (31-40 of 202) with videos related to

Pageof 21
Sort By:
Neuropharmacology|June 1, 1989
The dopamine agonist, PHNO ((+)-4-propyl-9-hydroxynaphthoxazine), inhibits cyclic adenosine 3',5'-monophosphate formation and prolactin release from anterior pituitary cellsI S Login, J M Trugman
Physical Review Letters|December 17, 2004
Exact ground states of a frustrated 2D magnet: deconfined fractional excitations at a first-order quantum phase transitionC D Batista, S A Trugman
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1992
Rapid development of dopaminergic supersensitivity in reserpine-treated rats demonstrated with 14C-2-deoxyglucose autoradiographyJ M Trugman, C L James
Clinical Pharmacology in Drug Development|July 12, 2024
Effect of a High-Fat Meal on the Pharmacokinetics of an Immediate Release Atogepant TabletRamesh R Boinpally, Joel M Trugman
Clinical and Translational Science|April 21, 2026
Ubrogepant Plasma and Cerebrospinal Fluid Exposures in Participants With a History of Migraine: Findings From a Phase 1b Open-Label TrialRamesh R Boinpally, Joel M Trugman
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 1993
Reversal of reserpine-induced catalepsy by selective D1 and D2 dopamine agonistsC A Hubbard, J M Trugman
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
The dopamine motor systemG F Wooten, J M Trugman
Ecology Letters|December 31, 2021
Climate change impacts plant carbon balance, increasing mean future carbon use efficiency but decreasing total forest extent at dry range edgesJustin M Mathias, Anna T Trugman
Brain Research|August 6, 1986
The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigraJ M Trugman, G F Wooten
Clinical and Translational Science|May 28, 2026
Cerebrospinal Fluid and Plasma Concentrations of Atogepant in HumansRamesh R Boinpally, Joel M Trugman
Pageof 21

Showing results (31-40 of 202) with videos related to

Sort By:
Pageof 21
Neuropharmacology|June 1, 1989
The dopamine agonist, PHNO ((+)-4-propyl-9-hydroxynaphthoxazine), inhibits cyclic adenosine 3',5'-monophosphate formation and prolactin release from anterior pituitary cellsI S Login, J M Trugman
Physical Review Letters|December 17, 2004
Exact ground states of a frustrated 2D magnet: deconfined fractional excitations at a first-order quantum phase transitionC D Batista, S A Trugman
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1992
Rapid development of dopaminergic supersensitivity in reserpine-treated rats demonstrated with 14C-2-deoxyglucose autoradiographyJ M Trugman, C L James
Clinical Pharmacology in Drug Development|July 12, 2024
Effect of a High-Fat Meal on the Pharmacokinetics of an Immediate Release Atogepant TabletRamesh R Boinpally, Joel M Trugman
Clinical and Translational Science|April 21, 2026
Ubrogepant Plasma and Cerebrospinal Fluid Exposures in Participants With a History of Migraine: Findings From a Phase 1b Open-Label TrialRamesh R Boinpally, Joel M Trugman
Movement Disorders : Official Journal of the Movement Disorder Society|October 1, 1993
Reversal of reserpine-induced catalepsy by selective D1 and D2 dopamine agonistsC A Hubbard, J M Trugman
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
The dopamine motor systemG F Wooten, J M Trugman
Ecology Letters|December 31, 2021
Climate change impacts plant carbon balance, increasing mean future carbon use efficiency but decreasing total forest extent at dry range edgesJustin M Mathias, Anna T Trugman
Brain Research|August 6, 1986
The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigraJ M Trugman, G F Wooten
Clinical and Translational Science|May 28, 2026
Cerebrospinal Fluid and Plasma Concentrations of Atogepant in HumansRamesh R Boinpally, Joel M Trugman
Pageof 21